98 related articles for article (PubMed ID: 23500518)
1. [D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice.
Novakovic ZM; Leinung MC; Grasso P
Peptides; 2013 May; 43():167-73. PubMed ID: 23500518
[TBL] [Abstract][Full Text] [Related]
2. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
Leinung MC; Grasso P
Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin-resistant C57BLK/6-m db/db mice.
Waldrop MA; Leinung MC; Lee DW; Grasso P
Diabetes Obes Metab; 2010 Oct; 12(10):871-5. PubMed ID: 20920039
[TBL] [Abstract][Full Text] [Related]
4. [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice.
Wang A; Anderson BM; Novakovic ZM; Grasso P
Peptides; 2018 Mar; 101():51-59. PubMed ID: 29269073
[TBL] [Abstract][Full Text] [Related]
5. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
[TBL] [Abstract][Full Text] [Related]
6. Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related synthetic peptide amide, significantly improves its pharmacokinetic profile and efficacy.
Novakovic ZM; Anderson BM; Grasso P
Peptides; 2014 Dec; 62():176-82. PubMed ID: 25453979
[TBL] [Abstract][Full Text] [Related]
7. Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation.
Rozhavskaya-Arena M; Lee DW; Leinung MC; Grasso P
Endocrinology; 2000 Jul; 141(7):2501-7. PubMed ID: 10875251
[TBL] [Abstract][Full Text] [Related]
8. The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice.
Lee DW; Leinung MC; Grasso P
Regul Pept; 2008 Oct; 150(1-3):62-5. PubMed ID: 18455249
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of mouse [d-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J wild-type and ob/ob mice: effects on energy balance, glycaemic control and serum osteocalcin levels.
Novakovic ZM; Leinung MC; Lee DW; Grasso P
Diabetes Obes Metab; 2010 Jun; 12(6):532-9. PubMed ID: 20518808
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems.
Novakovic ZM; Leinung MC; Lee DW; Grasso P
Regul Pept; 2009 Apr; 154(1-3):107-11. PubMed ID: 19344673
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice: a study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administration.
Lee DW; Leinung MC; Grasso P
Regul Pept; 2010 Feb; 160(1-3):129-32. PubMed ID: 20026361
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery of [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, synthetic peptide leptin mimetics: Immunofluorescent localization in the mouse hypothalamus.
Anderson BM; Jacobson L; Novakovic ZM; Grasso P
Brain Res; 2017 Jun; 1664():1-8. PubMed ID: 28347670
[TBL] [Abstract][Full Text] [Related]
13. MA-[D-Leu-4]-OB3, a small molecule synthetic peptide leptin mimetic, improves episodic memory, and reduces serum levels of tumor necrosis factor-alpha and neurodegeneration in mouse models of Type 1 and Type 2 Diabetes Mellitus.
Hirschstein Z; Vanga GR; Wang G; Novakovic ZM; Grasso P
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129697. PubMed ID: 32738275
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
Zhang XF; Tan BK
Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the metabolic effects of sustained CCK1 receptor activation alone and in combination with upregulated leptin signalling in high-fat-fed mice.
Irwin N; Montgomery IA; Flatt PR
Diabetologia; 2013 Jun; 56(6):1425-35. PubMed ID: 23462797
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Safety of MA-[D-Leu-4]-OB3, a Synthetic Peptide Leptin Mimetic: Two Pre-Clinical Toxicity Studies in Male and Female C57BL/6 Mice.
Enemark F; Novakovic ZM; Grasso P
Int J Toxicol; 2023 Dec; 42(6):504-514. PubMed ID: 37556196
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
18. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice.
Fu L; Bruckbauer A; Li F; Cao Q; Cui X; Wu R; Shi H; Zemel MB; Xue B
Metabolism; 2015 Jul; 64(7):845-56. PubMed ID: 25858853
[TBL] [Abstract][Full Text] [Related]
19. Biologically active leptin-related synthetic peptides activate STAT3 via phosphorylation of ERK1/2 and PI-3K.
Lin HY; Yang SH; Tang HY; Cheng GY; Davis PJ; Grasso P
Peptides; 2014 Jul; 57():95-100. PubMed ID: 24819473
[TBL] [Abstract][Full Text] [Related]
20. Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.
Derosa G; Cicero AF; Franzetti IG; Querci F; Carbone A; Ciccarelli L; D'Angelo A; Fogari E; Maffioli P
Can J Physiol Pharmacol; 2013 Sep; 91(9):724-32. PubMed ID: 23984793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
